ASPEN PHARMACARE HOLDINGS LIMITED
Incorporated in the Republic of South Africa
Registration number: 1985/002935/06
JSE Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
(“Aspen” or “the Group”)
DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR OF THE COMPANY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:
Director: Stephen Bradley Saad
Associate: K2019068922 (South Africa) Pty Ltd of which Stephen Bradley Saad is a
director
Date of transaction: 06 May 2025
Nature of transaction: On-market purchase of shares
Number of securities: 386,152
Price per security: 11,952.40 cents
Value of Transaction: R46,154,431.65
Class of securities: Ordinary shares
Nature of interest: Indirect beneficial
Clearance obtained: Yes
Director: Stephen Bradley Saad
Associate: K2019068922 (South Africa) Pty Ltd of which Stephen Bradley Saad is a
director
Date of transaction: 07 May 2025
Nature of transaction: On-market purchase of shares
Number of securities: 467,814
Price per security: 11,891.20 cents
Value of Transaction: R55,628,698.00
Class of securities: Ordinary shares
Nature of interest: Indirect beneficial
Clearance obtained: Yes
08 May 2025
Sponsor:
Investec Bank Limited